Breaking the gingival epithelial barrier: Role of the aggregatibacter actinomycetemcomitans cytolethal distending toxin in oral infectious disease

Cells

Volumn 3, Issue 2, 2014, Pages 476-499

  DiRienzo, Joseph M ^a  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Aggregatibacter actinomycetemcomitans; Cytolethal distending toxin; Gingival epithelial cells; Gingival epithelium; Gingival fibroblasts; Periodontal disease; Tissue

Indexed keywords

CYCLIN DEPENDENT KINASE 1; CYTOLETHAL DISTENDING TOXIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; OSTEOCLAST DIFFERENTIATION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL PHAGOCYTOSIS; CHROMOSOME ANALYSIS; CONNECTIVE TISSUE; CYTOTOXICITY; DNA DAMAGE; HUMAN; MORPHOLOGY; MOUTH INFECTION; NONHUMAN; PERIODONTAL DISEASE; PHYLOGENETIC TREE; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 84946544290     PISSN: None     EISSN: 20734409     Source Type: Journal    
DOI: 10.3390/cells3020476     Document Type: Review

References (129)

1. Norskov-Lauritsen, N.; Kilian, M. Reclassification of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, Haemophilus paraphrophilus; Haemophilus segnis as Aggregatibacter actinomycetemcomitans gen. nov., comb. nov., Aggregatibacter aphrophilus comb. nov. and Aggregatibacter segnis comb. nov., and emended description of Aggregatibacter aphrophilus to include V factor-dependent and V factor-independent isolates. Int. J. Syst. Evol. Microbiol. 2006, 56, 2135-2146.
2. Feder, H.M.J.; Roberts, J.C.; Salazar, J.; Leopold, H.B.; Toro-Salazar, O. HACEK endocarditis in infants and children: Two cases and a literature review. Pediatr. Infect. Dis. J. 2003, 22, 557-562.
3. Armitage, G.C. Comparison of the microbiological features of chronic and aggressive periodontitis. Periodontology 2010, 53, 70-88.
4. Darveau, R.P. Periodontitis: A polymicrobial disruption of host homeostasis. Nat. Rev. Microbiol. 2010, 8, 481-490.
5. Taubman, M.A.; Valverde, P.; Han, X.; Kawai, T. Immune response: The key to bone resorption in periodontal disease. J. Periodontol. 2005, 76, 2033-2041.
6. Lally, E.T.; Golub, E.E.; Kieba, I.R.; Taichman, N.S.; Rosenbloom, J.; Rosenbloom, J.C.; Gibson, C.W.; Demuth, D.R. Analysis of the Actinobacillus actinomycetemcomitans leukotoxin gene. Delineation of unique features and comparison to homologous toxins. J. Biol. Chem. 1989, 264, 15451-15456.
7. Mayer, M.P.; Bueno, L.C.; Hansen, E.J.; DiRienzo, J.M. Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect. Immun. 1999, 67, 1227-1237.
8. Feng, Z.; Weinberg, A. Role of bacteria in health and disease of periodontal tissues. Periodontol 2000, 40, 50-76.
9. Cortes-Bratti, X.; Chaves-Olarte, E.; Lagergård, T.; Thelestam, M. Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi. Infect. Immun. 2000, 68, 6903-6911.
10. Aberg, C.H.; Sjodin, B.; Lakio, L.; Pussinen, P.J.; Johansson, A.; Claesson, R. Presence of Aggregatibacter actinomycetemcomitans in young individuals: A 16-year clinical and microbiological follow-up study. J. Clin. Periodontol. 2009, 36, 815-822.
11. Ahmed, H.J.; Svensson, L.A.; Cope, L.D.; Latimer, J.L.; Hansen, E.J.; Ahlman, K.; Bayat-Turk, J.; Klamer, D.; Lagergård, T. Prevalence of cdtABC genes encoding cytolethal distending toxin among Haemophilus ducreyi and Actinobacillus actinomycetemcomitans strains. J. Med. Microbiol. 2001, 50, 860-864.
12. Bandhaya, P.; Saraithong, P.; Likittanasombat, K.; Hengprasith, B.; Torrungruang, K. Aggregatibacter actinomycetemcomitans serotypes, the JP2 clone and cytolethal distending toxin genes in a Thai population. J. Clin. Periodontol. 2012, 39, 519-525.
13. Fabris, A.S.; DiRienzo, J.M.; Wikstrom, M.; Mayer, M.P. Detection of cytolethal distending toxin activity and cdt genes in Actinobacillus actinomycetemcomitans isolates from geographically diverse populations. Oral Microbiol. Immunol. 2002, 17, 231-238.
14. Nishikubo, S.; Ohara, M.; Ikura, M.; Katayanagi, K.; Fujiwara, T.; Komatsuzawa, H.; Kurihara, H.; Sugai, M. Single nucleotide polymorphism in the cytolethal distending toxin B gene confers heterogeneity in the cytotoxicity of Actinobacillus actinomycetemcomitans. Infect. Immun. 2006, 74, 7014-7020.
15. Tan, K.S.; Song, K.P.; Ong, G. Cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Occurrence and association with periodontal disease. J. Periodontal. Res. 2002, 37, 268-272.
16. Yamano, R.; Ohara, M.; Nishikubo, S.; Fujiwara, T.; Kawamoto, T.; Ueno, Y.; Komatsuzawa, H.; Okuda, K.; Kurihara, H.; Suginaka, H.; et al. Prevalence of cytolethal distending toxin production in periodontopathogenic bacteria. J. Clin. Microbiol. 2003, 41, 1391-1398.
17. Ando, E.S.; De-Gennaro, L.A.; Faveri, M.; Feres, M.; DiRienzo, J.M.; Mayer, M.P. Immune response to cytolethal distending toxin of Aggregatibacter actinomycetemcomitans in periodontitis patients. J. Periodontal. Res. 2010, 45, 471-480.
18. Johansson, A.; Buhlin, K.; Koski, R.; Gustafsson, A. The immunoreactivity of systemic antibodies to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in adult periodontitis. Eur. J. Oral Sci. 2005, 113, 197-202.
19. Xynogala, I.; Volgina, A.; DiRienzo, J.M.; Korostoff, J. Evaluation of the humoral immune response to the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans Y4 in subjects with localized aggressive periodontitis. Oral Microbiol. Immunol. 2009, 24, 116-123.
20. DiRienzo, J.M.; Slots, J.; Sixou, M.; Sol, M.A.; Harmon, R.; McKay, T.L. Specific genetic variants of Actinobacillus actinomycetemcomitans correlate with disease and health in a regional population of families with localized juvenile periodontitis. Infect. Immun. 1994, 62, 3058-3065.
21. DiRienzo, J.M.; McKay, T.L. Identification and characterization of genetic cluster groups of Actinobacillus actinomycetemcomitans isolated from the human oral cavity. J. Clin. Microbiol. 1994, 32, 75-81.
22. Bueno, L.C.; Mayer, M.P.; DiRienzo, J.M. Relationship between conversion of localized juvenile periodontitis-susceptible children from health to disease and Actinobacillus actinomycetemcomitans leukotoxin promoter structure. J. Periodontol. 1998, 69, 998-1007.
23. Hoglund Aberg, C.; Antonoglou, G.; Haubek, D.; Kwamin, F.; Claesson, R.; Johansson, A. Cytolethal distending toxin in isolates of Aggregatibacter actinomycetemcomitans from Ghanaian adolescents and association with serotype and disease progression. PLoS One 2013, 8, e65781.
24. Wang, X.; Li, L.; Yang, M.; Geng, Y.; Chen, H.; Xu, Y.; Sun, Y. Prevalence and distribution of Aggregatibacter actinomycetemcomitans and its cdtB gene in subgingival plaque of Chinese periodontitis patients. BMC Oral Health 2014, 14, 37.
25. Gargi, A.; Reno, M.; Blanke, S.R. Bacterial toxin modulation of the eukaryotic cell cycle: Are all cytolethal distending toxins created equally? Front. Cell. Infect. Microbiol. 2012, 2, 124.
26. Akifusa, S.; Poole, S.; Lewthwaite, J.; Henderson, B.; Nair, S.P. Recombinant Actinobacillus actinomycetemcomitans cytolethal distending toxin proteins are required to interact to inhibit human cell cycle progression and to stimulate human leukocyte cytokine synthesis. Infect. Immun. 2001, 69, 5925-5930.
27. Mao, X.; DiRienzo, J.M. Functional studies of the recombinant subunits of a cytolethal distending holotoxin. Cell. Microbiol. 2002, 4, 245-255.
28. Saiki, K.; Konishi, K.; Gomi, T.; Nishihara, T.; Yoshikawa, M. Reconstitution and purification of cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiol. Immunol. 2001, 45, 497-506.
29. Yamada, T.; Komoto, J.; Saiki, K.; Konishi, K.; Takusagawa, F. Variation of loop sequence alters stability of cytolethal distending toxin (CDT): Crystal structure of CDT from Actinobacillus actinomycetemcomitans. Protein Sci. 2006, 15, 362-372.
30. McSweeney, L.A.; Dreyfus, L.A. Carbohydrate-binding specificity of the Escherichia coli cytolethal distending toxin CdtA-II and CdtC-II subunits. Infect. Immun. 2005, 73, 2051-2060.
31. Kanno, F.; Korostoff, J.; Volgina, A.; DiRienzo, J.M. Resistance of human periodontal ligament fibroblasts to the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. J. Periodontol. 2005, 76, 1189-1201.
32. Cao, L.; Volgina, A.; Huang, C.M.; Korostoff, J.; DiRienzo, J.M. Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Mol. Microbiol. 2005, 58, 1303-1321.
33. Lee, R.B.; Hassane, D.C.; Cottle, D.L.; Pickett, C.L. Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cells. Infect. Immun. 2003, 71, 4883-4890.
34. Akifusa, S.; Heywood, W.; Nair, S.P.; Stenbeck, G.; Henderson, B. Mechanism of internalization of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiology 2005, 151, 1395-1402.
35. Mise, K.; Akifusa, S.; Watarai, S.; Ansai, T.; Nishihara, T.; Takehara, T. Involvement of ganglioside GM3 in G2/M cell cycle arrest of human monocytic cells induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 2005, 73, 4846-4852.
36. Prokazova, N.V.; Samovilova, N.N.; Gracheva, E.V.; Golovanova, N.K. Ganglioside GM3 and its biological functions. Biochemistry (Moscow) 2009, 74, 235-249.
37. Boesze-Battaglia, K.; Brown, A.; Walker, L.; Besack, D.; Zekavat, A.; Wrenn, S.; Krummenacher, C.; Shenker, B.J. Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol. J. Biol. Chem. 2009, 284, 10650-10658.
38. Eshraghi, A.; Maldonado-Arocho, F.J.; Gargi, A.; Cardwell, M.M.; Prouty, M.G.; Blanke, S.R.; Bradley, K.A. Cytolethal distending toxin family members are differentially affected by alterations in host glycans and membrane cholesterol. J. Biol. Chem. 2010, 285, 18199-18207.
39. Carette, J.E.; Guimaraes, C.P.; Varadarajan, M.; Park, A.S.; Wuethrich, I.; Godarova, A.; Kotecki, M.; Cochran, B.H.; Spooner, E.; Ploegh, H.L.; et al. Haploid genetic screens in human cells identify host factors used by pathogens. Science 2009, 326, 1231-1235.
40. 2+-dependent neutral sphingomyelinase. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 5895-5900.
41. Cortes-Bratti, X.; Frisan, T.; Thelestam, M. The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon 2001, 39, 1729-1736.
42. Frisan, T.; Cortes-Bratti, X.; Chaves-Olarte, E.; Stenerlow, B.; Thelestam, M. The Haemophilus ducreyi cytolethal distending toxin induces DNA double-strand breaks and promotes ATM-dependent activation of RhoA. Cell. Microbiol. 2003, 5, 695-707.
43. 2+-dependent neutral nuclease. FEMS Microbiol. Lett. 2005, 251, 219-225.
44. Elwell, C.A.; Dreyfus, L.A. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol. Microbiol. 2000, 37, 952-963.
45. DiRienzo, J.M.; Cao, L.; Volgina, A.; Bandelac, G.; Korostoff, J. Functional and structural characterization of chimeras of a bacterial genotoxin and human type I DNAse. FEMS Microbiol. Lett. 2009, 291, 222-231.
46. Hu, X.; Nesic, D.; Stebbins, C.E. Comparative structure-function analysis of cytolethal distending toxins. Proteins 2006, 62, 421-434.
47. Lara-Tejero, M.; Galán, J.E. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000, 290, 354-357.
48. Nishikubo, S.; Ohara, M.; Ueno, Y.; Ikura, M.; Kurihara, H.; Komatsuzawa, H.; Oswald, E.; Sugai, M. An N-terminal segment of the active component of the bacterial genotoxin cytolethal distending toxin B (CDTB) directs CDTB into the nucleus. J. Biol. Chem. 2003, 278, 50671-50681.
49. Dlakic, M. Is CdtB a nuclease or a phosphatase? Science 2001, 291, 547.
50. Shenker, B.J.; Dlakic, M.; Walker, L.P.; Besack, D.; Jaffe, E.; Labelle, E.; Boesze-Battaglia, K. A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J. Immunol. 2007, 178, 5099-5108.
51. Shenker, B.J.; Walker, L.P.; Zekavat, A.; Dlakic, M.; Boesze-Battaglia, K. Blockade of the PI-3K signaling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines. Cell. Microbiol. 2014, doi: 10.1111/cmi.12299.
52. Hickey, T.E.; McVeigh, A.L.; Scott, D.A.; Michielutti, R.E.; Bixby, A.; Carroll, S.A.; Bourgeois, A.L.; Guerry, P. Campylobacter jejuni cytolethal distending toxin mediates release of interleukin-8 from intestinal epithelial cells. Infect. Immun. 2000, 68, 6535-6541.
53. Ando-Suguimoto, E.S.; da Silva, M.P.; Kawamoto, D.; Chen, C.; DiRienzo, J.M.; Mayer, M.P. The cytolethal distending toxin of Aggregatibacter actinomycetemcomitans inhibits macrophage phagocytosis and subverts cytokine production. Cytokine 2014, 66, 46-53.
54. Belibasakis, G.N.; Johansson, A.; Wang, Y.; Chen, C.; Kalfas, S.; Lerner, U.H. The cytolethal distending toxin induces receptor activator of NF-κB ligand expression in human gingival fibroblasts and periodontal ligament cells. Infect. Immun. 2005, 73, 342-351.
55. Belibasakis, G.N.; Johansson, A.; Wang, Y.; Chen, C.; Lagergård, T.; Kalfas, S.; Lerner, U.H. Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. Cytokine 2005, 30, 56-63.
56. Uchida, Y.; Shiba, H.; Komatsuzawa, H.; Takemoto, T.; Sakata, M.; Fujita, T.; Kawaguchi, H.; Sugai, M.; Kurihara, H. Expression of IL-1β and IL-8 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans. Cytokine 2001, 14, 152-161.
57. Belibasakis, G.N.; Brage, M.; Lagergård, T.; Johansson, A. Cytolethal distending toxin upregulates RANKL expression in Jurkat T-cells. Apmis 2008, 116, 499-506.
58. Hsu, H.; Lacey, D.L.; Dunstan, C.R.; Solovyev, I.; Colombero, A.; Timms, E.; Tan, H.L.; Elliott, G.; Kelley, M.J.; Sarosi, I.; et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 3540-3545.
59. Boyle, W.J.; Simonet, W.S.; Lacey, D.L. Osteoclast differentiation and activation. Nature 2003, 423, 337-342.
60. Liu, D.; Xu, J.K.; Figliomeni, L.; Huang, L.; Pavlos, N.J.; Rogers, M.; Tan, A.; Price, P.; Zheng, M.H. Expression of RANKL and OPG mRNA in periodontal disease: Possible involvement in bone destruction. Int. J. Mol. Med. 2003, 11, 17-21.
61. Mogi, M.; Ozeki, N.; Nakamura, H.; Togari, A. Dual roles for NF-κB activation in osteoblastic cells by serum deprivation: Osteoblastic apoptosis and cell-cycle arrest. Bone 2004, 35, 507-516.
62. Escalas, N.; Davezac, N.; de Rycke, J.; Baldin, V.; Mazars, R.; Ducommun, B. Study of the cytolethal distending toxin-induced cell cycle arrest in HeLa cells: Involvement of the CDC25 phosphatase. Exp. Cell Res. 2000, 257, 206-212.
63. Johnson, W.M.; Lior, H. A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb. Pathog. 1988, 4, 115-126.
64. Pérès, S.Y.; Marches, O.; Daigle, F.; Nougayrede, J.P.; Herault, F.; Tasca, C.; de Rycke, J.; Oswald, E. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol. Microbiol. 1997, 24, 1095-1107.
65. Sato, T.; Koseki, T.; Yamato, K.; Saiki, K.; Konishi, K.; Yoshikawa, M.; Ishikawa, I.; Nishihara, T. p53-independent expression of p21(CIP1/WAF1) in plasmacytic cells during G2 cell cycle arrest induced by Actinobacillus actinomycetemcomitans cytolethal distending toxin. Infect. Immun. 2002, 70, 528-534.
66. Sugai, M.; Kawamoto, T.; Pérès, S.Y.; Ueno, Y.; Komatsuzawa, H.; Fujiwara, T.; Kurihara, H.; Suginaka, H.; Oswald, E. The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect. Immun. 1998, 66, 5008-5019.
67. Whitehouse, C.A.; Balbo, P.B.; Pesci, E.C.; Cottle, D.L.; Mirabito, P.M.; Pickett, C.L. Campylobacter jejuni cytolethal distending toxin causes a G2-phase cell cycle block. Infect. Immun. 1998, 66, 1934-1940.
68. Cortes-Bratti, X.; Chaves-Olarte, E.; Lagergård, T.; Thelestam, M. The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J. Clin. Invest. 1999, 103, 107-115.
69. Stevens, M.K.; Latimer, J.L.; Lumbley, S.R.; Ward, C.K.; Cope, L.D.; Lagergård, T.; Hansen, E.J. Characterization of a Haemophilus ducreyi mutant deficient in expression of cytolethal distending toxin. Infect. Immun. 1999, 67, 3900-3908.
70. Smith, J.L.; Bayles, D.O. The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit. Rev. Microbiol. 2006, 32, 227-248.
71. Jinadasa, R.N.; Bloom, S.E.; Weiss, R.S.; Duhamel, G.E. Cytolethal distending toxin: A conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology 2011, 157, 1851-1875.
72. Oswald, E.; Nougayrede, J.P.; Taieb, F.; Sugai, M. Bacterial toxins that modulate host cell-cycle progression. Curr. Opin. Microbiol. 2005, 8, 83-91.
73. Comayras, C.; Tasca, C.; Pérès, S.Y.; Ducommun, B.; Oswald, E.; de Rycke, J. Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect. Immun. 1997, 65, 5088-5095.
74. Alaoui-El-Azher, M.; Mans, J.J.; Baker, H.V.; Chen, C.; Progulske-Fox, A.; Lamont, R.J.; Handfield, M. Role of the ATM-checkpoint kinase 2 pathway in CDT-mediated apoptosis of gingival epithelial cells. PLoS One 2010, 5, e11714.
75. Nougayrede, J.P.; Taieb, F.; de Rycke, J.; Oswald, E. Cyclomodulins: Bacterial effectors that modulate the eukaryotic cell cycle. Trends Microbiol. 2005, 13, 103-110.
76. DiRienzo, J.M.; Song, M.; Wan, L.S.; Ellen, R.P. Kinetics of KB and HEp-2 cell responses to an invasive, cytolethal distending toxin-producing strain of Actinobacillus actinomycetemcomitans. Oral Microbiol. Immunol. 2002, 17, 245-251.
77. Lepine, G.; Caudry, S.; DiRienzo, J.M.; Ellen, R.P. Epithelial cell invasion by Actinobacillus actinomycetemcomitans strains from restriction fragment-length polymorphism groups associated with juvenile periodontitis or carrier status. Oral Microbiol. Immunol. 1998, 13, 341-347.
78. Meyer, D.H.; Lippmann, J.E.; Fives-Taylor, P.M. Invasion of epithelial cells by Actinobacillus actinomycetemcomitans: A dynamic, multistep process. Infect. Immun. 1996, 64, 2988-2997.
79. Meyer, D.H.; Sreenivasan, P.K.; Fives-Taylor, P.M. Evidence for invasion of a human oral cell line by Actinobacillus actinomycetemcomitans. Infect. Immun. 1991, 59, 2719-2726.
80. Gilchrist, E.P.; Moyer, M.P.; Shillitoe, E.J.; Clare, N.; Murrah, V.A. Establishment of a human polyclonal oral epithelial cell line. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2000, 90, 340-347.
81. Kang, P.; Korostoff, J.; Volgina, A.; Grzesik, W.; DiRienzo, J.M. Differential effect of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans on co-cultures of human oral cells. J. Med. Microbiol. 2005, 54, 785-794.
82. Damek-Poprawa, M.; Haris, M.; Volgina, A.; Korostoff, J.; DiRienzo, J.M. Cytolethal distending toxin damages the oral epithelium of gingival explants. J. Dent. Res. 2011, 90, 874-879.
83. Belibasakis, G.; Johansson, A.; Wang, Y.; Claesson, R.; Chen, C.; Asikainen, S.; Kalfas, S. Inhibited proliferation of human periodontal ligament cells and gingival fibroblasts by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. Eur. J. Oral Sci. 2002, 110, 366-373.
84. Belibasakis, G.N.; Mattsson, A.; Wang, Y.; Chen, C.; Johansson, A. Cell cycle arrest of human gingival fibroblasts and periodontal ligament cells by Actinobacillus actinomycetemcomitans: involvement of the cytolethal distending toxin. Apmis 2004, 112, 674-685.
85. Bosshardt, D.D.; Lang, N.P. The junctional epithelium: From health to disease. J. Dent. Res. 2005, 84, 9-20.
86. Presland, R.B.; Dale, B.A. Epithelial structural proteins of the skin and oral cavity: Function in health and disease. Crit. Rev. Oral Biol. Med. 2000, 11, 383-408.
87. Bikle, D.D.; Oda, Y.; Xie, Z. Calcium and 1,25(OH)2D: Interacting drivers of epidermal differentiation. J. Steroid Biochem. Mol. Biol. 2004, 89, 355-360.
88. Christersson, L.A.; Albini, B.; Zambon, J.J.; Wikesjo, U.M.; Genco, R.J. Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. I. Light, immunofluorescence and electron microscopic studies. J. Periodontol. 1987, 58, 529-539.
89. Gibbons, R.J. Bacterial adhesion to oral tissues: A model for infectious diseases. J. Dent. Res. 1989, 68, 750-760.
90. Powell, R.N. Gingival tissue physiology in vitro. 3. Cell proliferation in gingival epithelium. J. Periodontal. Res. 1971, 6, 38-44.
91. Powell, R.N. Gingival tissue physiology in vitro. 1. Gingival organ culture. J. Periodontal. Res. 1967, 2, 290-296.
92. Ohara, M.; Miyauchi, M.; Tsuruda, K.; Takata, T.; Sugai, M. Topical application of Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces cell cycle arrest in the rat gingival epithelium in vivo. J. Periodontal. Res. 2011, 46, 389-395.
93. Franke, W.W. Discovering the molecular components of intercellular junctions-a historical view. Cold Spring Harb. Perspect. Biol. 2009, 1, a003061.
94. Cavey, M.; Lecuit, T. Molecular bases of cell-cell junctions stability and dynamics. Cold Spring Harb. Perspect. Biol. 2009, 1, a002998.
95. Shen, L. Tight junctions on the move: Molecular mechanisms for epithelial barrier regulation. Ann. N.Y. Acad. Sci. 2012, 1258, 9-18.
96. Miyaguchi, K. Ultrastructure of the zonula adherens revealed by rapid-freeze deep-etching. J. Struct. Biol. 2000, 132, 169-178.
97. Meng, W.; Takeichi, M. Adherens junction: Molecular architecture and regulation. Cold Spring Harb. Perspect. Biol. 2009, 1, a002899.
98. Kowalczyk, A.P.; Nanes, B.A. Adherens junction turnover: regulating adhesion through cadherin endocytosis, degradation, and recycling. Subcell. Biochem. 2012, 60, 197-222.
99. Hirokawa, N.; Heuser, J.E. Quick-freeze, deep-etch visualization of the cytoskeleton beneath surface differentiations of intestinal epithelial cells. J. Cell Biol. 1981, 91, 399-409.
100. Thilander, H.; Bloom, G.D. Cell contacts in oral epithelia. J. Periodontal. Res. 1968, 3, 96-110.
101. Barnett, M.L.; Szabo, G. Gap junctions in human gingival keratinized epithelium. J. Periodontal. Res. 1973, 8, 117-126.
102. Meyle, J.; Gultig, K.; Rascher, G.; Wolburg, H. Transepithelial electrical resistance and tight junctions of human gingival keratinocytes. J. Periodontal. Res. 1999, 34, 214-222.
103. Dickinson, B.C.; Moffatt, C.E.; Hagerty, D.; Whitmore, S.E.; Brown, T.A.; Graves, D.T.; Lamont, R.J. Interaction of oral bacteria with gingival epithelial cell multilayers. Mol. Oral Microbiol. 2011, 26, 210-220.
104. Katz, J.; Sambandam, V.; Wu, J.H.; Michalek, S.M.; Balkovetz, D.F. Characterization of Porphyromonas gingivalis-induced degradation of epithelial cell junctional complexes. Infect. Immun. 2000, 68, 1441-1449.
105. Damek-Poprawa, M.; Korostoff, J.; Gill, R.; DiRienzo, J.M. Cell junction remodeling in gingival tissue exposed to a microbial toxin. J. Dent. Res. 2013, 92, 518-523.
106. Furuse, M.; Hata, M.; Furuse, K.; Yoshida, Y.; Haratake, A.; Sugitani, Y.; Noda, T.; Kubo, A.; Tsukita, S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: A lesson from claudin-1-deficient mice. J. Cell Biol. 2002, 156, 1099-1111.
107. Ye, P.; Chapple, C.C.; Kumar, R.K.; Hunter, N. Expression patterns of E-cadherin, involucrin, and connexin gap junction proteins in the lining epithelia of inflamed gingiva. J. Pathol. 2000, 192, 58-66.
108. Downer, C.S.; Speight, P.M. E-cadherin expression in normal, hyperplastic and malignant oral epithelium. Eur. J. Cancer B Oral Oncol. 1993, 29B, 303-305.
109. Drees, F.; Pokutta, S.; Yamada, S.; Nelson, W.J.; Weis, W.I. Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly. Cell 2005, 123, 903-915.
110. Wheelock, M.J.; Knudsen, K.A. Cadherins and associated proteins. In Vivo 1991, 5, 505-513.
111. Brieher, W.M.; Yap, A.S. Cadherin junctions and their cytoskeleton(s). Curr. Opin. Cell Biol. 2012, 25, 1-8.
112. Yamada, S.; Pokutta, S.; Drees, F.; Weis, W.I.; Nelson, W.J. Deconstructing the cadherincatenin-actin complex. Cell 2005, 123, 889-901.
113. Aragon, V.; Chao, K.; Dreyfus, L.A. Effect of cytolethal distending toxin on F-actin assembly and cell division in Chinese hamster ovary cells. Infect. Immun. 1997, 65, 3774-3780.
114. Lagergard, T.; Keith, J. Cytolethal distending toxin as virulence factor, protective antigen, and target for vaccine development. Vaccine: Dev. Ther. 2012, 2, 51-60.
115. Ueno, Y.; Ohara, M.; Kawamoto, T.; Fujiwara, T.; Komatsuzawa, H.; Oswald, E.; Sugai, M. Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin. Infect. Immun. 2006, 74, 3480-3487.
116. Tan, K.S.; Ong, G.; Song, K.P. Introns in the cytolethal distending toxin gene of Actinobacillus actinomycetemcomitans. J. Bacteriol. 2005, 187, 567-575.
117. Jeon, B.; Itoh, K.; Ryu, S. Promoter analysis of cytolethal distending toxin genes (cdtA, B, and C) and effect of a luxS mutation on CDT production in Campylobacter jejuni. Microbiol. Immunol. 2005, 49, 599-603.
118. Coburn, J.; Leong, J.M. Microbiology. Arresting features of bacterial toxins. Science 2000, 290, 287-288.
119. Handfield, M.; Baker, H.V.; Lamont, R.J. Beyond good and evil in the oral cavity: Insights into host-microbe relationships derived from transcriptional profiling of gingival cells. J. Dent. Res. 2008, 87, 203-223.
120. Kagnoff, M.F.; Eckmann, L. Epithelial cells as sensors for microbial infection. J. Clin. Invest. 1997, 100, 6-10.
121. Nalbant, A.; Chen, C.; Wang, Y.; Zadeh, H.H. Induction of T-cell apoptosis by Actinobacillus actinomycetemcomitans mutants with deletion of ltxA and cdtABC genes: possible activity of GroEL-like molecule. Oral Microbiol. Immunol. 2003, 18, 339-349.
122. Shenker, B.J.; McKay, T.; Datar, S.; Miller, M.; Chowhan, R.; Demuth, D. Actinobacillus actinomycetemcomitans immunosuppressive protein is a member of the family of cytolethal distending toxins capable of causing a G2 arrest in human T cells. J. Immunol. 1999, 162, 4773-4780.
123. Shenker, B.J.; Hoffmaster, R.H.; Zekavat, A.; Yamaguchi, N.; Lally, E.T.; Demuth, D.R. Induction of apoptosis in human T cells by Actinobacillus actinomycetemcomitans cytolethal distending toxin is a consequence of G2 arrest of the cell cycle. J. Immunol. 2001, 167, 435-441.
124. Reed, J.C.; Meister, L.; Tanaka, S.; Cuddy, M.; Yum, S.; Geyer, C.; Pleasure, D. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin. Cancer Res. 1991, 51, 6529-6538.
125. Griffith, T.S.; Brunner, T.; Fletcher, S.M.; Green, D.R.; Ferguson, T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270, 1189-1192.
126. Ohara, M.; Hayashi, T.; Kusunoki, Y.; Miyauchi, M.; Takata, T.; Sugai, M. Caspase-2 and caspase-7 are involved in cytolethal distending toxin-induced apoptosis in Jurkat and MOLT-4 T-cell lines. Infect. Immun. 2004, 72, 871-879.
127. Ohara, M.; Hayashi, T.; Kusunoki, Y.; Nakachi, K.; Fujiwara, T.; Komatsuzawa, H.; Sugai, M. Cytolethal distending toxin induces caspase-dependent and-independent cell death in MOLT-4 cells. Infect. Immun. 2008, 76, 4783-4791.
128. Rabin, S.D.; Flitton, J.G.; Demuth, D.R. Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces apoptosis in nonproliferating macrophages by a phosphatase-independent mechanism. Infect. Immun. 2009, 77, 3161-3169.
129. Fernandes, K.P.; Mayer, M.P.; Ando, E.S.; Ulbrich, A.G.; Amarente-Mendes, J.G.; Russo, M. Inhibition of interferon-gamma-induced nitric oxide production in endotoxin-activated macrophages by cytolethal distending toxin. Oral Microbiol. Immunol. 2008, 23, 360-366.